Role of ISG15 in Inhibition of Ebola Virus Budding
Role of ISG15 in Inhibition of Ebola Virus Budding
批准号:
7927824
负责人:
RONALD N HARTY
金额:
$18.51万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-25 至 2011-08-31
关键词:
Antiviral AgentsBiologicalBiological AssayCategoriesCellsCollectionDataDemocratic Republic of the CongoDisease OutbreaksEbola virusEbola virus nucleoprotein VP40EnzymesEventFoundationsFutureGaggingGenesHIV-1HumanImmune responseImmune systemInfectionInfluenzaInterferonsKnowledgeLaboratoriesLearningLifeMediatingMolecularPlayProteinsRecombinantsRoleSindbis VirusSmall Interfering RNAStagingTSG101 geneTestingTransfectionUbiquitin Like ProteinsVesicular stomatitis Indiana virusViralViral GenomeViral Hemorrhagic FeversVirusVirus DiseasesVirus ReplicationVirus-like particleWestern Blottingbasegag Gene Productsinsightmutantpathogenpositional cloningresponsevirus host interaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ebola virus is a Category A virus and an emerging human pathogen that causes devastating outbreaks of hemorrhagic fever. Assembly and budding are important late events in the replication cycle of Ebola virus. While much has been learned regarding these dynamic and multifaceted stages of virus replication, the molecular mechanisms of assembly and budding remain unclear. This proposal focuses on the VP40 matrix protein of Ebola virus. Ebola VP40 protein contains late budding domains (L-domain) that play a key role in virus egress by mediating interactions with host proteins, such as tsg101. We hypothesize that host innate immune responses inhibit Ebola virus budding by targeting VP40 L-domain activity. Preliminary data implicate interferon stimulated gene 15 (ISG15) in inhibiting Ebola VP40 VLP budding. To test our hypothesis, we propose 3 Specific Aims: 1) To determine whether expression of ISG15 inhibits release of Ebola VP40 VLPs in an L-domain dependent manner, 2) To determine whether expression of ISG15 inhibits release of Ebola virus or VSV recombinants expressing Ebola virus L-domains, and 3) To determine whether expression of ISG15 inhibits Ebola VP40/host tsg101 interactions. Results from these studies should provide fundamental knowledge of how specific components of the innate immune response may inhibit Ebola virus budding, and provide the foundation for future studies to elucidate further the mechanisms and biological significance of these innate immune responses to Ebola virus infection.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2217/fvl.10.33
发表时间:
2010-07-01
期刊:
Future virology
影响因子:
3.1
作者:
[Liu Y, Harty RN]
通讯作者:
Harty RN
Role of Host Filamin Proteins in Regulating Filovirus Entry and Egress
-
批准号:10644499
-
项目类别:
-
资助金额:$26.83万
-
财政年份:2023
-
负责人:RONALD N HARTY
-
依托单位:
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
-
批准号:10688262
-
项目类别:
-
资助金额:$29.24万
-
财政年份:2022
-
负责人:RONALD N HARTY
-
依托单位:
Development of Host- Oriented Therapeutics Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),
-
批准号:10545109
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2022
-
负责人:RONALD N HARTY
-
依托单位:
Role of Host Angiomotin as a Central Regulator of Filovirus Egress and Dissemination
-
批准号:10380684
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2021
-
负责人:RONALD N HARTY
-
依托单位:
Role of Host Angiomotin as a Central Regulator of Filovirus Egress and Dissemination
-
批准号:10217843
-
项目类别:
-
资助金额:$28.58万
-
财政年份:2021
-
负责人:RONALD N HARTY
-
依托单位:
Modular Domains of Host Proteins Regulate Filovirus Maturation
-
批准号:9517218
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2018
-
负责人:RONALD N HARTY
-
依托单位:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
-
批准号:10257889
-
项目类别:
-
资助金额:$101.7万
-
财政年份:2018
-
负责人:RONALD N HARTY
-
依托单位:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
-
批准号:10368115
-
项目类别:
-
资助金额:$101.54万
-
财政年份:2018
-
负责人:RONALD N HARTY
-
依托单位:
Development of Small Molecule Therapeutics Targeting Hemorrhagic Fever Viruses
-
批准号:10599837
-
项目类别:
-
资助金额:$101.29万
-
财政年份:2018
-
负责人:RONALD N HARTY
-
依托单位:
DEVELOPMENT OF SMALL MOLECULE THERAPEUTICS AGAINST RNA VIRUSES
-
批准号:8903846
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2015
-
负责人:RONALD N HARTY
-
依托单位:
Innate Immune Regulation of Intracellular Pathways Involved in Filovirus Budding
-
批准号:8635498
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2013
-
负责人:RONALD N HARTY
-
依托单位:
Host-Oriented Therapeutics Targeting Filovirus Budding.
-
批准号:8853616
-
项目类别:
-
资助金额:$46.66万
-
财政年份:2012
-
负责人:RONALD N HARTY
-
依托单位:
Host-Oriented Therapeutics Targeting Filovirus Budding.
-
批准号:8490299
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2012
-
负责人:RONALD N HARTY
-
依托单位:
Host-Oriented Therapeutics Targeting Filovirus Budding.
-
批准号:8389432
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2012
-
负责人:RONALD N HARTY
-
依托单位:
Host-Oriented Therapeutics Targeting Filovirus Budding.
-
批准号:9088302
-
项目类别:
-
资助金额:$47.28万
-
财政年份:2012
-
负责人:RONALD N HARTY
-
依托单位:
Innate Immune Defenses Against Filoviruses.
-
批准号:8076883
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2010
-
负责人:RONALD N HARTY
-
依托单位:
Innate Immune Defenses Against Filoviruses.
-
批准号:7964676
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2010
-
负责人:RONALD N HARTY
-
依托单位:
Packaging of Ebola Virus RNA into Budding VLPs
-
批准号:7339650
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2007
-
负责人:RONALD N HARTY
-
依托单位:
Role of ISG15 in Inhibition of Ebola Virus Budding
-
批准号:7391373
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2007
-
负责人:RONALD N HARTY
-
依托单位:
Packaging of Ebola Virus RNA into Budding VLPs
-
批准号:7176652
-
项目类别:
-
资助金额:$23.59万
-
财政年份:2007
-
负责人:RONALD N HARTY
-
依托单位:
海外基金